Dyadic International (DYAI) News Today → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free DYAI Stock Alerts $2.18 -0.09 (-3.96%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 2 at 9:21 AM | marketbeat.comDyadic International, Inc. (NASDAQ:DYAI) Short Interest Down 8.3% in MayDyadic International, Inc. (NASDAQ:DYAI - Get Free Report) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 177,500 shares, a decline of 8.3% from the April 30th total of 193,600 shares. Approximately 0.9% of the shares of the company are sold short. Based on an average trading volume of 31,600 shares, the short-interest ratio is presently 5.6 days.May 30 at 4:30 PM | globenewswire.comDyadic to Attend Industry Events in JuneMay 25, 2024 | americanbankingnews.comDyadic International (NASDAQ:DYAI) Share Price Crosses Above 50-Day Moving Average of $1.62May 19, 2024 | msn.comDyadic International, Inc. (NASDAQ:DYAI) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comDYAI: Product Revenues Next YearMay 15, 2024 | finance.yahoo.comDyadic International Inc (DYAI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review ...May 14, 2024 | investorplace.comDYAI Stock Earnings: Dyadic International Reported Results for Q1 2024May 14, 2024 | msn.comDyadic International GAAP EPS of -$0.07, revenue of $0.34MMay 14, 2024 | globenewswire.comDyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 14, 2024 | investing.comDyadic (DYAI) Earnings Dates & ReportsMay 8, 2024 | globenewswire.comDyadic to Attend Industry and Investor Events in MayMay 7, 2024 | investing.comDyadic International Inc (DYAI)May 4, 2024 | fool.comDyadic International (NASDAQ: DYAI)April 30, 2024 | globenewswire.comDyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024April 24, 2024 | msn.comDyadic International files to sell 3.35M shares for holdersApril 1, 2024 | msn.comDYAI: Capital Raise to Accelerate Near Term Revenue GrowthApril 1, 2024 | insidermonkey.comDyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comDyadic International, Inc. (DYAI) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 Dyadic International Inc Earnings CallMarch 28, 2024 | benzinga.comRecap: Dyadic International Q4 EarningsMarch 28, 2024 | globenewswire.comDyadic Reports 2023 Full Year Results and Recent Company ProgressMarch 28, 2024 | globenewswire.comDyadic Announces Change in Board and Management Leadership RolesMarch 27, 2024 | globenewswire.comDyadic to Attend Industry Events in AprilMarch 26, 2024 | globenewswire.comDyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature CommunicationsMarch 21, 2024 | globenewswire.comDyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, CaliforniaMarch 14, 2024 | globenewswire.comDyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024March 11, 2024 | finance.yahoo.comDyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationMarch 11, 2024 | globenewswire.comCORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationMarch 11, 2024 | globenewswire.comDyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationMarch 1, 2024 | globenewswire.comDyadic to Attend Industry Events in MarchFebruary 29, 2024 | ca.finance.yahoo.comDYAI Aug 2024 2.500 callFebruary 29, 2024 | ca.finance.yahoo.comDYAI Apr 2024 2.500 callFebruary 28, 2024 | msn.comDyadic announces strategic partnership agreement to develop rabies vaccinesFebruary 28, 2024 | globenewswire.comDyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production PlatformFebruary 23, 2024 | globenewswire.comDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsFebruary 21, 2024 | finance.yahoo.comDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsFebruary 21, 2024 | finance.yahoo.comDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsFebruary 21, 2024 | globenewswire.comDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsFebruary 20, 2024 | finance.yahoo.comDYAI: Catching Up With DyadicFebruary 6, 2024 | msn.comDyadic signs R&D agreement with global biopharmaceutical companyFebruary 1, 2024 | finance.yahoo.comDyadic to Attend BIO CEO & Investor Conference and European Industry EventsJanuary 22, 2024 | finance.yahoo.comDyadic International, Inc Invites You to Join Us at The Microcap ConferenceJanuary 3, 2024 | morningstar.comDyadic International Inc DYAINovember 30, 2023 | finance.yahoo.comDyadic Attends Investor Events in DecemberNovember 29, 2023 | finance.yahoo.comDyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine CandidateNovember 22, 2023 | finance.yahoo.comShareholders in Dyadic International (NASDAQ:DYAI) are in the red if they invested three years agoNovember 20, 2023 | markets.businessinsider.comDyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in AfricaNovember 20, 2023 | finance.yahoo.comDyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in AfricaNovember 13, 2023 | markets.businessinsider.comDyadic International’s Promising Outlook: COVID-19 Vaccine Progress, Strategic Collaborations, and Financial StabilityNovember 9, 2023 | finance.yahoo.comDYAI: Third Quarter Update Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit DYAI Media Mentions By Week DYAI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DYAI News Sentiment▼1.030.76▲Average Medical News Sentiment DYAI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DYAI Articles This Week▼41▲DYAI Articles Average Week Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Champions Oncology News Brainstorm Cell Therapeutics News Genfit News Coherus BioSciences News Compugen News Monte Rosa Therapeutics News Elevation Oncology News Scilex News Acumen Pharmaceuticals News Compass Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DYAI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.